Cancer risk assessment of ethyl carbamate in alcoholic beverages from Brazil with special consideration to the spirits cachaca and tiquira

Detalhes bibliográficos
Autor(a) principal: Lachenmeier, Dirk W.
Data de Publicação: 2010
Outros Autores: Lima, Maria Cristina Pereira [UNESP], Nobrega, Ian C. C., Pereira, Jose A. P., Kerr-Corrêa, Florence [UNESP], Kanteres, Fotis, Rehm, Juergen
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNESP
Texto Completo: http://dx.doi.org/10.1186/1471-2407-10-266
http://hdl.handle.net/11449/12471
Resumo: Background: Ethyl carbamate ( EC) is a multi-site carcinogen in experimental animals and probably carcinogenic to humans (IARC group 2A). Traces of EC below health-relevant ranges naturally occur in several fermented foods and beverages, while higher concentrations above 1 mg/l are regularly detected in only certain spirits derived from cyanogenic plants. In Brazil this concerns the sugarcane spirit cachaca and the manioc (cassava) spirit tiquira, which both regularly exceed the national EC limit of 0.15 mg/l. This study aims to estimate human exposure in Brazil and provide a quantitative risk assessment.Methods: The human dietary intake of EC via alcoholic beverages was estimated based on WHO alcohol consumption data in combination with own surveys and literature data. This data comprises the EC contents of the different beverage groups cachaca, tiquira, other spirits, beer, wine, and unrecorded alcohol (as defined by the WHO; including alcohol which is not captured in routine government statistics nor taxed). The risk assessment was conducted using the margin of exposure (MOE) approach with benchmark doses obtained from dose-response modelling of animal experiments. Lifetime cancer risk was calculated using the T25 dose descriptor.Results: Considering differences between pot-still and column-still cachaca, its average EC content would be 0.38 mg/l. Tiquira contained a considerably higher average EC content of 2.34 mg/l. The whole population exposure from all alcoholic beverages was calculated to be around 100 to 200 ng/kg bw/day, with cachaca and unrecorded alcohol as the major contributing factors. The MOE was calculated to range between 400 and 2,466, with the lifetime cancer risk at approximately 3 cases in 10,000. An even higher risk may exist for binge-drinkers of cachaca and tiquira with MOEs of up to 80 and 15, respectively.Conclusions: According to our risk assessment, EC poses a significant cancer risk for the alcohol-drinking population in Brazil, in addition to that of alcohol alone. Model calculations show that the implementation of the 0.15 mg/l limit for cachaca would be beneficial, including an increase of the MOE by a factor between 3 to 6. The implementation of policy measures for tiquira and unrecorded alcohol also appears to be advisable.
id UNSP_30b1a43299bbe18ec094d4001fb1e0ff
oai_identifier_str oai:repositorio.unesp.br:11449/12471
network_acronym_str UNSP
network_name_str Repositório Institucional da UNESP
repository_id_str 2946
spelling Cancer risk assessment of ethyl carbamate in alcoholic beverages from Brazil with special consideration to the spirits cachaca and tiquiraBackground: Ethyl carbamate ( EC) is a multi-site carcinogen in experimental animals and probably carcinogenic to humans (IARC group 2A). Traces of EC below health-relevant ranges naturally occur in several fermented foods and beverages, while higher concentrations above 1 mg/l are regularly detected in only certain spirits derived from cyanogenic plants. In Brazil this concerns the sugarcane spirit cachaca and the manioc (cassava) spirit tiquira, which both regularly exceed the national EC limit of 0.15 mg/l. This study aims to estimate human exposure in Brazil and provide a quantitative risk assessment.Methods: The human dietary intake of EC via alcoholic beverages was estimated based on WHO alcohol consumption data in combination with own surveys and literature data. This data comprises the EC contents of the different beverage groups cachaca, tiquira, other spirits, beer, wine, and unrecorded alcohol (as defined by the WHO; including alcohol which is not captured in routine government statistics nor taxed). The risk assessment was conducted using the margin of exposure (MOE) approach with benchmark doses obtained from dose-response modelling of animal experiments. Lifetime cancer risk was calculated using the T25 dose descriptor.Results: Considering differences between pot-still and column-still cachaca, its average EC content would be 0.38 mg/l. Tiquira contained a considerably higher average EC content of 2.34 mg/l. The whole population exposure from all alcoholic beverages was calculated to be around 100 to 200 ng/kg bw/day, with cachaca and unrecorded alcohol as the major contributing factors. The MOE was calculated to range between 400 and 2,466, with the lifetime cancer risk at approximately 3 cases in 10,000. An even higher risk may exist for binge-drinkers of cachaca and tiquira with MOEs of up to 80 and 15, respectively.Conclusions: According to our risk assessment, EC poses a significant cancer risk for the alcohol-drinking population in Brazil, in addition to that of alcohol alone. Model calculations show that the implementation of the 0.15 mg/l limit for cachaca would be beneficial, including an increase of the MOE by a factor between 3 to 6. The implementation of policy measures for tiquira and unrecorded alcohol also appears to be advisable.Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)São Paulo State Univ, Dept Neurol Psicol & Psiquiatria, Botucatu Med Sch UNESP, BR-18618970 São Paulo, BrazilChem & Vet Untersuchungsamt CVUA Karlsruhe, D-76187 Karlsruhe, GermanyUniv Fed Rural Pernambuco, Programa Posgrad Ciência & Tecnol Alimentos, BR-52171900 Recife, PE, BrazilCAMH, Toronto, on M5S 2S1, CanadaMaastricht Univ, Fac Hlth Med & Life Sci, NL-6200 MD Maastricht, NetherlandsUniv Toronto, Dalla Lana Sch Publ Hlth, Toronto, on M5T 3M7, CanadaTech Univ Dresden, Epidemiol Res Unit, Inst Clin Psychol & Psychotherapy, D-01187 Dresden, GermanySão Paulo State Univ, Dept Neurol Psicol & Psiquiatria, Botucatu Med Sch UNESP, BR-18618970 São Paulo, BrazilCNPq: 578384/2008-6Biomed Central Ltd.Universidade Estadual Paulista (Unesp)Chem & Vet Untersuchungsamt CVUA KarlsruheUniversidade Federal Rural de Pernambuco (UFRPE)CAMHMaastricht UnivUniv TorontoTech Univ DresdenLachenmeier, Dirk W.Lima, Maria Cristina Pereira [UNESP]Nobrega, Ian C. C.Pereira, Jose A. P.Kerr-Corrêa, Florence [UNESP]Kanteres, FotisRehm, Juergen2014-05-20T13:36:11Z2014-05-20T13:36:11Z2010-06-08info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article15application/pdfhttp://dx.doi.org/10.1186/1471-2407-10-266Bmc Cancer. London: Biomed Central Ltd., v. 10, p. 15, 2010.1471-2407http://hdl.handle.net/11449/1247110.1186/1471-2407-10-266WOS:000279792100003WOS000279792100003.pdf2169124595816290Web of Sciencereponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengBMC Cancer3.2881,464info:eu-repo/semantics/openAccess2023-12-28T06:14:11Zoai:repositorio.unesp.br:11449/12471Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestopendoar:29462023-12-28T06:14:11Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false
dc.title.none.fl_str_mv Cancer risk assessment of ethyl carbamate in alcoholic beverages from Brazil with special consideration to the spirits cachaca and tiquira
title Cancer risk assessment of ethyl carbamate in alcoholic beverages from Brazil with special consideration to the spirits cachaca and tiquira
spellingShingle Cancer risk assessment of ethyl carbamate in alcoholic beverages from Brazil with special consideration to the spirits cachaca and tiquira
Lachenmeier, Dirk W.
title_short Cancer risk assessment of ethyl carbamate in alcoholic beverages from Brazil with special consideration to the spirits cachaca and tiquira
title_full Cancer risk assessment of ethyl carbamate in alcoholic beverages from Brazil with special consideration to the spirits cachaca and tiquira
title_fullStr Cancer risk assessment of ethyl carbamate in alcoholic beverages from Brazil with special consideration to the spirits cachaca and tiquira
title_full_unstemmed Cancer risk assessment of ethyl carbamate in alcoholic beverages from Brazil with special consideration to the spirits cachaca and tiquira
title_sort Cancer risk assessment of ethyl carbamate in alcoholic beverages from Brazil with special consideration to the spirits cachaca and tiquira
author Lachenmeier, Dirk W.
author_facet Lachenmeier, Dirk W.
Lima, Maria Cristina Pereira [UNESP]
Nobrega, Ian C. C.
Pereira, Jose A. P.
Kerr-Corrêa, Florence [UNESP]
Kanteres, Fotis
Rehm, Juergen
author_role author
author2 Lima, Maria Cristina Pereira [UNESP]
Nobrega, Ian C. C.
Pereira, Jose A. P.
Kerr-Corrêa, Florence [UNESP]
Kanteres, Fotis
Rehm, Juergen
author2_role author
author
author
author
author
author
dc.contributor.none.fl_str_mv Universidade Estadual Paulista (Unesp)
Chem & Vet Untersuchungsamt CVUA Karlsruhe
Universidade Federal Rural de Pernambuco (UFRPE)
CAMH
Maastricht Univ
Univ Toronto
Tech Univ Dresden
dc.contributor.author.fl_str_mv Lachenmeier, Dirk W.
Lima, Maria Cristina Pereira [UNESP]
Nobrega, Ian C. C.
Pereira, Jose A. P.
Kerr-Corrêa, Florence [UNESP]
Kanteres, Fotis
Rehm, Juergen
description Background: Ethyl carbamate ( EC) is a multi-site carcinogen in experimental animals and probably carcinogenic to humans (IARC group 2A). Traces of EC below health-relevant ranges naturally occur in several fermented foods and beverages, while higher concentrations above 1 mg/l are regularly detected in only certain spirits derived from cyanogenic plants. In Brazil this concerns the sugarcane spirit cachaca and the manioc (cassava) spirit tiquira, which both regularly exceed the national EC limit of 0.15 mg/l. This study aims to estimate human exposure in Brazil and provide a quantitative risk assessment.Methods: The human dietary intake of EC via alcoholic beverages was estimated based on WHO alcohol consumption data in combination with own surveys and literature data. This data comprises the EC contents of the different beverage groups cachaca, tiquira, other spirits, beer, wine, and unrecorded alcohol (as defined by the WHO; including alcohol which is not captured in routine government statistics nor taxed). The risk assessment was conducted using the margin of exposure (MOE) approach with benchmark doses obtained from dose-response modelling of animal experiments. Lifetime cancer risk was calculated using the T25 dose descriptor.Results: Considering differences between pot-still and column-still cachaca, its average EC content would be 0.38 mg/l. Tiquira contained a considerably higher average EC content of 2.34 mg/l. The whole population exposure from all alcoholic beverages was calculated to be around 100 to 200 ng/kg bw/day, with cachaca and unrecorded alcohol as the major contributing factors. The MOE was calculated to range between 400 and 2,466, with the lifetime cancer risk at approximately 3 cases in 10,000. An even higher risk may exist for binge-drinkers of cachaca and tiquira with MOEs of up to 80 and 15, respectively.Conclusions: According to our risk assessment, EC poses a significant cancer risk for the alcohol-drinking population in Brazil, in addition to that of alcohol alone. Model calculations show that the implementation of the 0.15 mg/l limit for cachaca would be beneficial, including an increase of the MOE by a factor between 3 to 6. The implementation of policy measures for tiquira and unrecorded alcohol also appears to be advisable.
publishDate 2010
dc.date.none.fl_str_mv 2010-06-08
2014-05-20T13:36:11Z
2014-05-20T13:36:11Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1186/1471-2407-10-266
Bmc Cancer. London: Biomed Central Ltd., v. 10, p. 15, 2010.
1471-2407
http://hdl.handle.net/11449/12471
10.1186/1471-2407-10-266
WOS:000279792100003
WOS000279792100003.pdf
2169124595816290
url http://dx.doi.org/10.1186/1471-2407-10-266
http://hdl.handle.net/11449/12471
identifier_str_mv Bmc Cancer. London: Biomed Central Ltd., v. 10, p. 15, 2010.
1471-2407
10.1186/1471-2407-10-266
WOS:000279792100003
WOS000279792100003.pdf
2169124595816290
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv BMC Cancer
3.288
1,464
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 15
application/pdf
dc.publisher.none.fl_str_mv Biomed Central Ltd.
publisher.none.fl_str_mv Biomed Central Ltd.
dc.source.none.fl_str_mv Web of Science
reponame:Repositório Institucional da UNESP
instname:Universidade Estadual Paulista (UNESP)
instacron:UNESP
instname_str Universidade Estadual Paulista (UNESP)
instacron_str UNESP
institution UNESP
reponame_str Repositório Institucional da UNESP
collection Repositório Institucional da UNESP
repository.name.fl_str_mv Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)
repository.mail.fl_str_mv
_version_ 1803047146827546624